Chapter 19: Concepts of Cancer Development

The foundation of understanding cancer involves recognizing how proto-oncogenes and tumor suppressor genes maintain a delicate equilibrium in healthy cells, controlling growth and division while allowing programmed cell death when appropriate. Cancer emerges when genetic mutations disrupt this balance, permitting cells to divide without restraint and lose their normal characteristics including proper morphology, specialized function, and contact inhibition. The pathological transformation occurs through a multistage process beginning with initiation, where carcinogenic agents such as chemicals, radiation, or viruses cause permanent DNA damage to cellular genes. Promotion follows when growth-stimulating factors like hormones accelerate division of these initiated cells. Progression involves accumulation of additional mutations that grant tumors independence from normal regulatory controls and enable them to produce their own blood supply through vascular endothelial growth factor secretion. Metastasis represents the final critical stage, allowing malignant cells to invade surrounding tissues and spread through circulatory and lymphatic pathways to establish secondary tumors in distant organs. Cancer classification depends on tissue origin and distinguishes between solid tumors and hematologic malignancies, with grading systems assessing cellular differentiation level and staging systems determining anatomic extent through the TNM framework. The chapter synthesizes three pivotal risk categories: external carcinogens including tobacco, radiation exposure, ultraviolet light, and oncogenic viruses; genetic predisposition through inherited mutations in suppressor genes that increase susceptibility to specific cancer types; and immune function decline that reduces surveillance capacity against abnormal cells. Prevention strategies span multiple levels, from primary prevention through lifestyle modification and carcinogen avoidance, to secondary prevention emphasizing early detection via screening programs and genetic testing for high-risk individuals. The nurse plays an essential role in patient education regarding modifiable risk factors, promotion of appropriate screening protocols, and recognition of warning signs that warrant clinical evaluation.